Stay updated with breaking news from Early Development Engine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna continues development of at least 15 vaccine programs targeting emerging or neglected infectious diseases by 2025 as part of global health programModerna is committed to clinical trial diversity
Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025Moderna launches mRNA Access, a new collaborative
Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical stu...
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its global public health strategy through four new initiatives aimed at advancing mRNA vaccines for the prevention of infectious diseases. First, Moderna is announcing a commitment to ...
MODERNA ANNOUNCES ITS GLOBAL PUBLIC HEALTH STRATEGYMARCH 07, 2022Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025Moderna launches mRNA Access, a new collaborative enabling researchers around the world to uti...